Company profile
Kallyope
- Industry
- Biotechnology Research
- Employees
- 56
- Headquarters
- New York, New York
- LinkedIn followers
- 8,318
- Office locations
- 1
Kallyope company summary
Kallyope is a company in the Biotechnology Research industry, headquartered in New York, New York. On LinkedIn the company has around 56 employees and 8,318 followers. Its listed specialties include Biotechnology, Pharmaceuticals, Metabolism, Migraine, Neurology.
What technology does Kallyope use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Kallyope
At Kallyope, we are leveraging unique insights into neural signaling pathways and developing innovative medicines for the treatment of migraine and metabolic disorders. Our late-stage pipeline focuses on delivering effective, easy to use, and well-tolerated agents based on novel neural circuits. Kallyope was founded by world-leading neuroscientists whose groundbreaking research into previously unexplored neural networks is now being carried forward by a team of experienced drug developers. Based in New York City, our accomplished scientists and drug developers bring together agile innovation and real-world focus to create major value for patients. Our pipeline is enabled by the Klarity™ Platform, including our lead migraine candidate moving into pivotal studies for the acute treatment of migraine, and our novel metabolism programs based on a novel feeding circuit set to enter clinical studies in mid-2026.
Specialties
Where is Kallyope located?
Kallyope lists 1 location.
Compare companies similar to Kallyope
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Kallyope kallyope.com | Biotechnology Research | 56 | - | New York, New York |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Kallyope
What does Kallyope do?
At Kallyope, we are leveraging unique insights into neural signaling pathways and developing innovative medicines for the treatment of migraine and metabolic disorders. Our late-stage pipeline focuses on delivering effective, easy to use, and well-tolerated agents based on novel neural circuits. Kallyope was founded by world-leading neuroscientists whose groundbreaking research into previously unexplored neural networks is now being carried forward by a team of experienced drug developers. Based in New York City, our accomplished scientists and drug developers bring together agile innovation and real-world focus to create major value for patients. Our pipeline is enabled by the Klarity™ Platform, including our lead migraine candidate moving into pivotal studies for the acute treatment of migraine, and our novel metabolism programs based on a novel feeding circuit set to enter clinical studies in mid-2026.
How many employees does Kallyope have?
Kallyope has around 56 employees on LinkedIn.
Where is Kallyope headquartered?
Kallyope is headquartered in New York, New York.
Build a lead list from companies like Kallyope
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.